{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:50:11Z","timestamp":1793350211640,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T00:00:00Z","timestamp":1458777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00330-016-4308-4","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T06:18:01Z","timestamp":1458800281000},"page":"4345-4353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["68Ga-PSMA I&amp;T PET\/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging"],"prefix":"10.1007","volume":"26","author":[{"given":"Thorsten","family":"Derlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Weiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"von Klot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Henkenberens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel S.","family":"Merseburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,24]]},"reference":[{"key":"4308_CR1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M et al (2013) PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486\u2013495","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4308_CR2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","volume":"56","author":"M Weineisen","year":"2015","unstructured":"Weineisen M, Schottelius M, Simecek J et al (2015) 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies. J Nucl Med 56:1169\u20131176","journal-title":"J Nucl Med"},{"key":"4308_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2967\/jnumed.115.156133","volume":"56","author":"K Herrmann","year":"2015","unstructured":"Herrmann K, Bluemel C, Weineisen M et al (2015) Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy. J Nucl Med 56:855\u2013861","journal-title":"J Nucl Med"},{"key":"4308_CR4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M et al (2015) Evaluation of Hybrid 68Ga-PSMA Ligand PET\/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy. J Nucl Med 56:668\u2013674","journal-title":"J Nucl Med"},{"key":"4308_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","volume":"42","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Avtzi E, Giesel FL et al (2015) The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 42:197\u2013209","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4308_CR6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2967\/jnumed.112.104661","volume":"53","author":"SY Cho","year":"2012","unstructured":"Cho SY, Gage KL, Mease RC et al (2012) Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J Nucl Med 53:1883\u20131891","journal-title":"J Nucl Med"},{"key":"4308_CR7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2967\/jnumed.114.147413","volume":"56","author":"M Bene\u0161ov\u00e1","year":"2015","unstructured":"Bene\u0161ov\u00e1 M, Sch\u00e4fer M, Bauder-W\u00fcst U et al (2015) Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer. J Nucl Med 56:914\u2013920","journal-title":"J Nucl Med"},{"key":"4308_CR8","first-page":"2674","volume":"5","author":"SS Chang","year":"1999","unstructured":"Chang SS, O'Keefe DS, Bacich DJ et al (1999) Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 5:2674\u20132681","journal-title":"Clin Cancer Res"},{"key":"4308_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-014-0063-1","volume":"4","author":"M Weineisen","year":"2014","unstructured":"Weineisen M, Simecek J, Schottelius M et al (2014) Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer. EJNMMI Res 4:63","journal-title":"EJNMMI Res"},{"key":"4308_CR10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1148\/rg.254045155","volume":"25","author":"N Subhas","year":"2005","unstructured":"Subhas N, Patel PV, Pannu HK et al (2005) Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET. Radiographics 25:1031\u20131043","journal-title":"Radiographics"},{"key":"4308_CR11","first-page":"353","volume":"44","author":"K Koyama","year":"2003","unstructured":"Koyama K, Okamura T, Kawabe J et al (2003) Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. J Nucl Med 44:353\u2013358","journal-title":"J Nucl Med"},{"key":"4308_CR12","first-page":"1803","volume":"47","author":"EM Kamel","year":"2006","unstructured":"Kamel EM, Jichlinski P, Prior JO et al (2006) Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies. J Nucl Med 47:1803\u20131807","journal-title":"J Nucl Med"},{"key":"4308_CR13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2967\/jnumed.106.036350","volume":"48","author":"DA Anjos","year":"2007","unstructured":"Anjos DA, Etchebehere EC, Ramos CD et al (2007) 18F-FDG PET\/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med 48:764\u2013770","journal-title":"J Nucl Med"},{"key":"4308_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00259-012-2294-6","volume":"40","author":"B Nayak","year":"2013","unstructured":"Nayak B, Dogra PN, Naswa N et al (2013) Diuretic 18F-FDG PET\/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Eur J Nucl Med Mol Imaging 40:386\u2013393","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4308_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Haberkorn U, Schlemmer HP et al (2014) Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging 41:887\u2013897","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4308_CR16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00259-015-3078-6","volume":"42","author":"F Ceci","year":"2015","unstructured":"Ceci F, Uprimny C, Nilica B et al (2015) 68Ga-PSMA PET\/CT for restaging recurrent prostate cancer: which factors are associated with PET\/CT detection rate? Eur J Nucl Med Mol Imaging 42:1284\u20131294","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4308_CR17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nucmedbio.2013.09.002","volume":"41","author":"R Martin","year":"2014","unstructured":"Martin R, J\u00fcttler S, M\u00fcller M, Wester HJ (2014) Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2. Nucl Med Biol 41:84\u201389","journal-title":"Nucl Med Biol"},{"key":"4308_CR18","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1007\/s00330-008-1080-0","volume":"18","author":"G M\u00fchlenbruch","year":"2008","unstructured":"M\u00fchlenbruch G, Behrendt FF, Eddahabi MA et al (2008) Which Iodine concentration in chest CT?--a prospective study in 300 patients. Eur Radiol 18:2826\u20132832","journal-title":"Eur Radiol"},{"key":"4308_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11307-015-0866-0","volume":"17","author":"M Dietlein","year":"2015","unstructured":"Dietlein M, Kobe C, Kuhnert G et al (2015) Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer. Mol Imaging Biol 17:575\u2013584","journal-title":"Mol Imaging Biol"},{"key":"4308_CR20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2015.04.034","volume":"68","author":"T Maurer","year":"2015","unstructured":"Maurer T, Weirich G, Schottelius M et al (2015) Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer. Eur Urol 68:530\u2013534","journal-title":"Eur Urol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4308-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-016-4308-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4308-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4308-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T08:00:21Z","timestamp":1559030421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-016-4308-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,24]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1007\/s00330-016-4308-4","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,24]]}}}